COMPASS PATHWAYS PLC Other Non-Current Assets
COMPASS PATHWAYS PLC (CMPS) had Other Non-Current Assets of $20.39 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Noncurrent $20.39M.
- 2026-03-31: Other Assets, Noncurrent $13.91M.
- 2025-12-31: Other Assets, Noncurrent $11.68M.
- 2025-09-30: Other Assets, Noncurrent $4.76M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $20.39M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $13.91M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $11.68M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $4.76M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $8.50M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $8.18M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $6.59M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $6.52M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $6.24M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $6.10M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $7.05M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $5.88M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $7.44M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $212.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.41M 10-K · filed 2024-02-29 | $327.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $299.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $410.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $334.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $213.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $219.00K 6-K · filed 2021-11-09 | |
| 2021-06-30 | $43.00K 6-K · filed 2021-08-11 | |
| 2020-12-31 | $57.00K 10-K · filed 2022-02-24 | |
| 2019-12-31 | $0.00 20-F · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |